• Science & Technology
• Health & Medicine

New bladder cancer therapy to start clinical trials

An experimental treatment for bladder cancer will move into an early phase clinical trial under an agreement signed today. An experimental treatment for bladder cancer will move into an early phase clinical trial under an agreement signed today.

26 June 2017

• Health & Medicine

Tumour characteristics could predict immunotherapy success in lung cancer

The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found. The molecular make-up of lung tumours could help identify patients who might benefit from immunotherapy treatment up front, a new study has found.

23 June 2017

• Health & Medicine
• Science & Technology

8 new challenges between us and beating cancer

We launch phase 2 of our Grand Challenge with 8 of the biggest questions in cancer research. We launch phase 2 of our Grand Challenge with 8 of the biggest questions in cancer research.

22 June 2017

• For Supporters

Cancer Research UK sets out latest £20m Grand Challenges to beat cancer sooner

Cancer Research UK launches the second phase of its global Grand Challenge, with eight new questions identified as some of the biggest barriers to progress. Cancer Research UK launches the second phase of its global Grand Challenge, with eight new questions identified as some of the biggest barriers to progress.

22 June 2017

• Science & Technology
• Health & Medicine

Study estimates breast and ovarian cancer risk linked to faulty BRCA genes

A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer. A new study has estimated the ages at which women with faults in two particular genes are most at risk of developing breast and ovarian cancer.

20 June 2017

• Science & Technology
• Health & Medicine

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine. Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

19 June 2017

• Health & Medicine

Discovery could guide immunotherapy for lung cancer

Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment. Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.

19 June 2017

• Health & Medicine

Blood test could help personalise treatment for advanced prostate cancer

Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer. Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.

19 June 2017

• Science & Technology
• Health & Medicine

News digest - smoking rates falling, aspirin risks, breast cancer drug U-turn and… ‘tanning drugs’?

Smoking rates are falling, aspirin has risks as well as benefits and… what's behind the talk of ‘tanning drugs’? Here's our weekly news report. Smoking rates are falling, aspirin has risks as well as benefits and… what's behind the talk of ‘tanning drugs’? Here's our weekly news report.

17 June 2017

• Science & Technology

Certain genetic faults could help predict success of immunotherapy

A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study. A certain group of genetic faults could be used to help predict if immunotherapy will work in cancer patients, according to a new US study.

9 June 2017

• Health & Medicine

Combining immunotherapies could benefit some aggressive breast cancers

Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study. Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.

8 June 2017

• Science & Technology
• Health & Medicine

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer. We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.

6 June 2017